GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: Neulasta®
pegfilgrastim is an approved drug (FDA and EMA (2002))
Compound class:
Peptide
Comment: This is a PEGylated version of recombinant human G-CSF. Pegylation increases circulating half-life. In addition to pegfilgrastim, lipegfilgrastim (Lonquex®) is a glyco-PEGylated long-acting G-CSF, that is an alternative to pegfilgrastim [1].
Biosimilars:
|
Classification ![]() |
|
Compound class | Peptide |
Approved drug? | Yes. EU EMA (2002) | US FDA (2002) |
International Nonproprietary Names ![]() |
|
INN number | INN |
8114 | pegfilgrastim |
Synonyms ![]() |
Neulasta® |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 616 |
Other databases | |
CAS Registry No. | 208265-92-3 (source: Scifinder) |
ChEMBL Ligand | CHEMBL1201568 |
DrugBank Ligand | DB00019 |
GtoPdb PubChem SID | 178103549 |
Search PubMed clinical trials | pegfilgrastim |
Search PubMed titles | pegfilgrastim |
Search PubMed titles/abstracts | pegfilgrastim |
Wikipedia | Pegfilgrastim |